{"id":"W3208129759","doi":"10.1038/s41575-021-00523-4","title":"Advancing the global public health agenda for NAFLD: a consensus statement","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Gastroenterology & Hepatology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":736,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; McGill University Health Centre; University of British Columbia; University Health Network","funders":"Janssen Pharmaceuticals; Sanofi-Aventis Deutschland; Novartis Pharma; Genentech; Julius Clinical; European Association for the Study of the Liver; Novo Nordisk Fonden; Shionogi; Astellas Pharma; Novo Nordisk; Arrowhead Pharmaceuticals; Coherus Biosciences; Intercept Pharmaceuticals; Takeda Pharmaceuticals International; Galecto; Rosetrees Trust; Regeneron Pharmaceuticals; European Federation of Pharmaceutical Industries and Associations; Medpace; Celgene; Alexion Pharmaceuticals; Servier; Gilead Sciences; City University of New York; Alnylam Pharmaceuticals; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; Allergan; AstraZeneca; Amgen; NGM Biopharmaceuticals; Pfizer; National Institute for Health and Care Research; Medicines Company; Falk Foundation","keywords":"Medicine; Statement (logic); Public health; Global health; Consensus conference; MEDLINE; Mission statement; Public relations; Political science; Nursing; Internal medicine; Law","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04785969,0.001823028,0.002624006,0.004952239,0.001745835,0.005655533,0.003954844,0.01252173,0.006024718],"category_scores_gemma":[0.04007547,0.0009907754,0.003615366,0.003859919,0.002426452,0.01060466,0.006380278,0.0177153,0.003519558],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005282579,"about_ca_system_score_gemma":0.0370672,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002833556,"about_ca_topic_score_gemma":0.003674718,"domain_scores_codex":[0.9829714,0.008216675,0.002434043,0.0007648448,0.004625932,0.0009871389],"domain_scores_gemma":[0.9593515,0.01882245,0.002605917,0.0008827097,0.0140593,0.004278154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009782201,0.0001778122,0.0003567743,0.03816479,0.0001748006,0.0006182253,0.001976069,0.0008784142,0.001059075,0.02805053,0.5057026,0.4227432],"study_design_scores_gemma":[0.00005143441,0.0000729837,0.0005894456,0.05891231,0.0001658153,0.0005778347,0.001302354,0.0002361024,0.0001386083,0.01810632,0.9197868,0.00005997993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.0004597007,0.3980447,0.00461316,0.5557762,0.03477305,0.0006047244,0.0003332507,0.0001247712,0.005270538],"genre_scores_gemma":[0.007607856,0.7710853,0.03098013,0.1661454,0.0137128,0.001625218,0.00162607,0.00007364633,0.007143577],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.04785969,"threshold_uncertainty_score":0.2531092,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08817425077180643,"score_gpt":0.4313828959297201,"score_spread":0.3432086451579136,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}